3,6-Dihydro-6,6-diMethyl-2-propyl-3-[[2'-[2-(triphenylMethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]Methyl]-4H-furo[3,4-d]iMidazol-4-one

 化学構造式
1048948-15-7
CAS番号.
1048948-15-7
化学名:
别名:
英語名:
3,6-Dihydro-6,6-diMethyl-2-propyl-3-[[2'-[2-(triphenylMethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]Methyl]-4H-furo[3,4-d]iMidazol-4-one
英語别名:
Olmesartan?Impurity?47;Olmesartan Medoxomil-6;Olmesartan ester impurity G;Olmesartan Medoxomil Impurity G;Olmesartan Medoxomil Impurity14;Azilsartan medoxomil impurity236;Olmesartan medoxomil Cyclic impurty N2-Trityl;4,4-dimethyl-2-propyl-1-((2'-(2-trityl-2H-tetrazol-5-yl);6,6-dimethyl-2-propyl-3-((2'-(2-trityl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-3,6-dihydro-4H-furo[3,4-d]imidazol-4-one;3,6-Dihydro-6,6-diMethyl-2-propyl-3-[[2'-[2-(triphenylMethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]Methyl]-4H-furo[3,4-d]iMidazol-4-one
CBNumber:
CB32729861
化学式:
C43H38N6O2
分子量:
670.8
MOL File:
1048948-15-7.mol

3,6-Dihydro-6,6-diMethyl-2-propyl-3-[[2'-[2-(triphenylMethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]Methyl]-4H-furo[3,4-d]iMidazol-4-one 物理性質

融点 :
165-167°C
貯蔵温度 :
-20°C Freezer
溶解性:
クロロホルム(微量)、ジクロロメタン(微量)
外見 :
個体
色:
白い

安全性情報

3,6-Dihydro-6,6-diMethyl-2-propyl-3-[[2'-[2-(triphenylMethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]Methyl]-4H-furo[3,4-d]iMidazol-4-one 価格

メーカー 製品番号 製品説明 CAS番号 包装 価格 更新時間 購入

3,6-Dihydro-6,6-diMethyl-2-propyl-3-[[2'-[2-(triphenylMethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]Methyl]-4H-furo[3,4-d]iMidazol-4-one 化学特性,用途語,生産方法

使用

3,6-Dihydro-6,6-dimethyl-2-propyl-3-[[2''-[2-(triphenylmethyl)-2H-tetrazol-5-yl][1,1''-biphenyl]-4-yl]methyl]-4H-furo[3,4-d]imidazol-4-one is an impurity of Olmesartan Medoxomil (O550000), which is an angiotensin II receptor antagonist used to treat high blood pressure.

3,6-Dihydro-6,6-diMethyl-2-propyl-3-[[2'-[2-(triphenylMethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]Methyl]-4H-furo[3,4-d]iMidazol-4-one 上流と下流の製品情報

原材料

準備製品


3,6-Dihydro-6,6-diMethyl-2-propyl-3-[[2'-[2-(triphenylMethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]Methyl]-4H-furo[3,4-d]iMidazol-4-one 生産企業

Global( 46)Suppliers
名前 電話番号 電子メール 国籍 製品カタログ 優位度
Standardpharm Co. Ltd.
86-714-3992388
overseasales1@yongstandards.com United States 14336 58
BOC Sciences
+1-631-485-4226
inquiry@bocsci.com United States 19553 58
Career Henan Chemica Co
+86-0371-86658258 15093356674;
laboratory@coreychem.com China 30255 58
Hangzhou Huarong Pharm Co., Ltd.
571-86758373 +8613588754946
sales@huarongpharm.com CHINA 3149 58
Amadis Chemical Company Limited
571-89925085
sales@amadischem.com China 131980 58
Shanghai Payne Pharmaceutical Technology Co.Ltd
021-58123769 18678586262
info@paynepharm.com China 1354 58
Chemsky(shanghai)International Co.,Ltd. 021-50135380
shchemsky@sina.com China 32344 50
Beijing Comparison Pharmaceutical Technology Co., Ltd 010-52878169 15701683040
sales@bjcomparison.com China 4713 58
ChemStrong Scientific Co.,Ltd 0755-0755-66853366 13670046396
sales@chem-strong.com China 17993 56
Wuxi Zhongkun Biochemical Technology Co., Ltd. 0510-85629785 18013409632
sales@reading-chemicals.com China 15185 58

1048948-15-7()キーワード:


  • 1048948-15-7
  • 3,6-Dihydro-6,6-diMethyl-2-propyl-3-[[2'-[2-(triphenylMethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]Methyl]-4H-furo[3,4-d]iMidazol-4-one
  • 6,6-dimethyl-2-propyl-3-((2'-(2-trityl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-3,6-dihydro-4H-furo[3,4-d]imidazol-4-one
  • Olmesartan Medoxomil Impurity G
  • Olmesartan medoxomil Cyclic impurty N2-Trityl
  • Olmesartan Medoxomil impurity 15/Olmesartan Medoxomil Cyclic Impurty N2-Trityl/6,6-dimethyl-2-propyl-3-((2'-(2-trityl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-3,6-dihydro-4H-furo[3,4-d]imidazol-4-one
  • 4,4-dimethyl-2-propyl-1-((2'-(2-trityl-2H-tetrazol-5-yl)
  • Olmesartan Medoxomil-6
  • 4H-Furo[3,4-d]imidazol-4-one, 3,6-dihydro-6,6-dimethyl-2-propyl-3-[[2'-[2-(triphenylmethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-
  • Azilsartan medoxomil impurity236
  • Olmesartan Medoxomil Impurity14
  • Olmesartan?Impurity?47
  • Olmesartan ester impurity G
Copyright 2017 © ChemicalBook. All rights reserved